[1] 徐家芳, 谢永登.沙门氏菌研究进展[J].广西畜牧兽医, 2020, 36(2):92-94. XU J F, XIE Y D.Research progress of Salmonella[J].Guangxi Journal of Animal Husbandry Veterinary Medicine, 2020, 36(2):92-94.(in Chinese) [2] 李星, 王雪敏, 邵玉新, 等.鸽沙门氏菌病及其抗生素替代品防控措施研究进展[J].中国畜牧兽医, 2021, 48(7):2584-2593. LI X, WANG X M, SHAO Y X, et al.Research progress on pigeon salmonellosis and control measures of antibiotic substitutes[J].China Animal Husbandry & Veterinary Medicine, 2021, 48(7):2584-2593.(in Chinese) [3] 李正田, 豆腾飞, 李琦华, 等.中草药复方防治雏鸡沙门氏菌病的研究[J].中国畜牧兽医, 2020, 47(3):911-921. LI Z T, DOU T F, LI Q H, et al.Study on the prevention and treatment of salmonellosis in chicks with Chinese herbal medicine compound[J].China Animal Husbandry & Veterinary Medicine, 2020, 47(3):911-921.(in Chinese) [4] RIVERA-CHÁVEZ F, ZHANG L F, FABER F, et al.Depletion of butyrate-producing Clostridia from the gut microbiota drives an aerobic luminal expansion of Salmonella[J].Cell Host & Microbe, 2016, 19(4):443-454. [5] ROGERS A W L, TSOLIS R M, BÄUMLER A J.Salmonella versus the Microbiome[J].Microbiology and Molecular Biology Reviews, 2020, 85(1):e00027-19. [6] POPA G L, PAPA M I.Salmonella spp.infection-A continuous threat worldwide[J].Germs, 2021, 11(1):88-96. [7] 郑林, 祝令伟, 郭学军, 等.沙门氏菌主要流行血清型耐药性的研究进展[J].江苏农业科学, 2020, 48(6):8-12. ZHENG L, ZHU L W, GUO X J, et al.Research progress of antimicrobial resistance of major epidemic serotypes of Salmonella[J].Jiangsu Agricultural Science, 2020, 48(6):8-12.(in Chinese) [8] 董晓璐, 秦晓杰, 刘阳泰, 等.食源性沙门氏菌在人体胃肠道中耐受及致病机制研究进展[J].食品与发酵工业, 2021, 47(24):286-292. DONG X L, QIN X J, LIU Y T, et al.Research progress on tolerance and pathogenic mechanism of foodborne Salmonella spp.in human gastrointestinal tract[J].Food and Fermentation Industries, 2021, 47(24):286-292.(in Chinese) [9] FEASEY N A, HADFIELD J, KEDDY K H, et al.Distinct Salmonella Enteritidis lineages associated with enterocolitis in high-income settings and invasive disease in low-income settings[J]. Nature Genetics, 2016, 48(10):1211-1217. [10] FISKIN E, BIONDA T, DIKIC I, et al.Global analysis of host and bacterial ubiquitinome in response to Salmonella Typhimurium infection[J].Molecular Cell, 2016, 62(6):967-981. [11] KIYUNA T, MURAKAMI T, TOME Y, et al.High efficacy of tumor-targeting Salmonella Typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model[J].Oncotarget, 2016, 7(22):33046-33054. [12] LV Q, LV Y, DOU X, et al.Myricetin inhibits the type Ⅲ secretion system of Salmonella enterica serovar Typhimurium by downregulating the Salmonella pathogenic island Ⅰ gene regulatory pathway[J].Microbial Pathogenesis, 2021, 150:104695. [13] AL-TAWEEL F B, DOUGLAS C W I, WHAWELL S A.The periodontal pathogen Porphyromonas gingivalis preferentially interacts with oral epithelial cells in S phase of the cell cycle[J].Infection and Immunity, 2016, 84(7):1966-1974. [14] KNUFF-JANZEN K, TUPIN A, YURIST-DOUTSCH S, et al.Multiple Salmonella-pathogenicity island 2 effectors are required to facilitate bacterial establishment of its intracellular niche and virulence[J].PLoS One, 2020, 15(6):e0235020. [15] LAWRENCE A E, ABUAITA B H, BERGER R P, et al.Salmonella enterica serovar Typhimurium SPI-1 and SPI-2 shape the global transcriptional landscape in a human intestinal organoid model system[J].mBio, 2021, 12(3):399-401. [16] DE SOUZA SANTOS M, ORTH K.The role of the type Ⅲ secretion system in the intracellular lifestyle of enteric pathogens[J].Microbiology Spectrum, 2019, 7(3):BAI-0008-2019. [17] HEMN M, WEI D, RACHEL O, et al.Host-derived Spi6 provides granzyme B-independent protection of intestinal epithelial cells in murine GVHD[J]. Biology of Blood and Marrow Transplantation, 2018, 24(12):2397-2408. [18] PRADHAN D, NEGI V D.Repeated in-vitro and in-vivo exposure leads to genetic alteration, adaptations, and hypervirulence in Salmonella[J].Microbial Pathogenesis 2019, 136:103654. [19] FU Y, GALÁN J E.The Salmonella Typhimurium tyrosine phosphatase SptP is translocated into host cells and disrupts the actin cytoskeleton[J].Molecular Microbiology, 1998, 27(2):359-368. [20] MURLI S, WATSON R O, GALÁN J E.Role of tyrosine kinases and the tyrosine phosphatase SptP in the interaction of Salmonella with host cells[J].Cellular Microbiology, 2001, 3(12):795-810. [21] HARAGA A, MILLER S I.A Salmonella enterica serovar Typhimurium translocated leucine-rich repeat effector protein inhibits NF-kappa B-dependent gene expression[J].Infection and Immunity, 2003, 71(7):4052-4058. [22] LIN S L, LE T X, COWEN D S.SptP, a Salmonella Typhimurium type Ⅲ-secreted protein, inhibits the mitogen-activated protein kinase pathway by inhibiting Raf activation[J].Cellular Microbiology, 2003, 5(4):267-275. [23] FU Y, GALÁN J E.A Salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion[J].Nature, 1999, 401(6750):293-297. [24] HUMPHREYS D, HUME P J, KORONAKIS V.The Salmonella effector SptP dephosphorylates host AAA+ ATPase VCP to promote development of its intracellular replicative niche[J].Cell Host Microbe, 2009, 5(3):225-233. [25] JIA S, MCWHORTER A R, ANDREWS D M, et al.Challenges in vaccinating layer hens against Salmonella Typhimurium[J].Vaccines, 2020, 8(4):696-708. [26] XIA S, HENDRIKSEN R S, XIE Z, et al.Molecular characterization and antimicrobial susceptibility of Salmonella isolates from infections in humans in Henan province, China[J]. Journal of Clinical Microbiology, 2009, 47(2):401-409. [27] KE B, SUN J, HE D, et al.Serovar distribution, antimicrobial resistance profiles, and PFGE typing of Salmonella enterica strains isolated from 2007-2012 in Guangdong, China[J]. BMC Infectious Diseases, 2014, 14(1):338. [28] JOHNSON R, MYLONA E, FRANKEL G.Typhoidal Salmonella:Distinctive virulence factors and pathogenesis[J].Cellular Microbiology, 2018, 20(9):e12939. [29] DENG Q, BARBIERI J T.Modulation of host cell endocytosis by the type Ⅲ cytotoxin, Pseudomonas ExoS[J].Traffic, 2008, 9(11):1948-1957. [30] CHOI H W, BROOKING-DIXON R, NEUPANE S, et al.Salmonella Typhimurium impedes innate immunity with a mast-cell-suppressing protein tyrosine phosphatase, SptP[J]. Immunity, 2013, 39(6):1108-1120. [31] LIN Z, TANG P, JIAO Y, et al.Immunogenicity and protective efficacy of a Salmonella Enteritidis SptP mutant as a live attenuated vaccine candidate[J].BMC Veterinary Research, 2017, 13(1):194. [32] LEBLANC M A, FINK M R, PERKINS T T, et al.Type Ⅲ secretion system effector proteins are mechanically labile[J].Proceedings of the National Academy of Sciences of the United States of America, 2021, 118(12):e2019566118. [33] HAYASHI F, KAWASHIMA Y, TAKEUCHI S, et al.SptP106-136 plays a role in the complex formation with SptP-specific chaperone SicP[J].Bioscience, Biotechnology & Biochemistry, 2014, 78(9):1560-1563. [34] MILETIC S, FAHRENKAMP D, GOESSWEINER-MOHR N, et al.Substrate-engaged type Ⅲ secretion system structures reveal gating mechanism for unfolded protein translocation[J].Nature Communications, 2021, 12(1):1546. [35] 杨江流, 乔军伟, 宋青山, 等.布鲁氏菌S19毒力基因BvfA的原核表达及生物信息学分析[J].中国畜牧兽医, 2021, 48(8):2746-2753. YANG J L, QIAO J W, SONG Q S, et al.Prokaryotic expression and bioinformatics analysis of virulence gene BvfA of Brucella S19[J].China Animal Husbandry & Veterinary Medicine, 2021, 48(8):2746-2753.(in Chinese) |